GlassScriptPhysician profile
Deanna M Bianchini
NPI 1538645999
$7,738.31
in general payments reported to CMS, 2019-2025
70 companies · $1,817 in 2025
The $1,817 reported for 2025 was more than what 90% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $705 · 2022: $1,236 · 2023: $2,011 · 2024: $1,970 · 2025: $1,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,797.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $967.59 | 2021-2025 | |
| Janssen Biotech, INC. | $454.75 | 2021-2025 | Erleada, Talvey, Darzalex |
| Incyte Corporation | $436.13 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Genzyme Corporation | $433.70 | 2021-2025 | |
| Abbvie INC. | $419.90 | 2022-2025 | |
| Daiichi Sankyo INC. | $366.47 | 2022-2025 | Enhertu, Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $295.07 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $277.24 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $273.14 | 2022-2025 | |
| Lilly USA, LLC | $263.03 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $184.93 | 2024-2025 | Polivy, Venclexta, Tecentriq |
| Seagen INC. | $180.13 | 2021-2023 | Tukysa, Adcetris, Padcev |
| Pharmacosmos Therapeutics INC. | $164.34 | 2021-2025 | Monoferric |
| Amgen INC. | $157.79 | 2022-2023 | Kyprolis, Blincyto, Vectibix |
| Morphosys, US INC. | $134.59 | 2022-2023 | Monjuvi |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $110.12 | 2021-2023 | Imbruvica, Epkinly |
| Regeneron Healthcare Solutions, INC. | $108.29 | 2023-2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $105.04 | 2023-2025 | Ninlaro, Fruzaqla, Vpriv |
| Emd Serono, INC. | $102.08 | 2023-2025 | Bavencio |
| Alexion Pharmaceuticals, INC. | $101.62 | 2022-2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $99.90 | 2023-2024 | Enhertu, Calquence |
| E.R. Squibb & Sons, L.L.C. | $94.85 | 2021-2025 | Krazati, Augtyro, Opdivo |
| Ipsen Biopharmaceuticals, INC | $94.70 | 2023-2025 | Somatuline Depot, Onivyde |
| Pfizer INC. | $84.27 | 2021-2025 | |
| Beigene USA, INC. | $83.59 | 2022-2024 | Brukinsa |
| Genmab U.S., INC. | $79.63 | 2024-2025 | Tivdak, Epkinly |
| Celgene Corporation | $67.66 | 2022-2025 | Reblozyl, Opdualag |
| Rigel Pharmaceuticals, INC. | $66.00 | 2022-2024 | Tavalisse, Rezlidhia |
| Glaxosmithkline, LLC. | $65.69 | 2021-2025 | Zejula, Jemperli, Ojjaara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.83 | 2021-2022 | |
| G1 Therapeutics, INC. | $63.01 | 2022 | |
| Eagle Pharmaceuticals, INC. | $61.36 | 2024 | |
| Puma Biotechnology, INC. | $60.21 | 2023-2024 | |
| Gilead Sciences, INC. | $57.75 | 2023-2024 | Trodelvy |
| Exelixis INC. | $57.28 | 2021-2025 | Cabometyx |
| Deciphera Pharmaceuticals INC. | $56.62 | 2021-2025 | Qinlock, Tgct |
| Kyowa Kirin, INC. | $56.13 | 2021-2023 | Poteligeo |
| Acrotech Biopharma INC. | $55.48 | 2023-2025 | Beleodaq |
| Kite Pharma, INC. | $53.88 | 2022-2023 | Yescarta |
| Tempus Ai, INC | $49.80 | 2024 | Xt Cdx |
| Myovant Sciences INC. | $48.25 | 2021 | |
| Aveo Pharmaceuticals, INC. | $48.07 | 2023-2025 | Fotivda |
| Tersera Therapeutics LLC | $44.39 | 2022-2024 | Zoladex |
| Jazz Pharmaceuticals INC. | $42.99 | 2022-2024 | |
| Adc Therapeutics America, INC. | $36.22 | 2022-2023 | |
| Stemline Therapeutics INC. | $33.30 | 2023 | Orserdu |
| Cumberland Pharmaceuticals, INC. | $33.14 | 2024-2025 | Sancuso |
| Emmaus Medical, INC. | $33.05 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $33.00 | 2023-2024 | |
| Beone Medicines USA, INC. | $32.49 | 2025 | Brukinsa |
| Karyopharm Therapeutics INC. | $30.46 | 2025 | Xpovio |
| Foundation Medicine, INC. | $29.95 | 2022 | |
| Immunogen, INC. | $28.88 | 2023 | Elahere |
| Astellas Pharma US INC | $28.83 | 2025 | Vyloy |
| Taiho Oncology, INC. | $27.19 | 2022 | |
| Aadi Bioscience, INC. | $24.58 | 2023 | Fyarro |
| Boston Scientific Corporation | $23.69 | 2025 | Wavewriter Alpha Prime 16 |
| Sobi, INC | $22.88 | 2023 | |
| Mirati Therapeutics, INC. | $22.82 | 2024 | Krazati |
| Secura Bio, INC. | $22.61 | 2025 | Copiktra |
| Pharmaessentia USA Corporation | $22.19 | 2024 | Besremi |
| Eusa Pharma (US) LLC | $20.94 | 2022 | |
| Apellis Pharmaceuticals, INC. | $20.12 | 2023 | Empaveli |
| Array Biopharma INC | $20.04 | 2025 | Lorbrena, Xalkori, Braftovi |
| Recordati_rare_diseases_inc. | $18.90 | 2024 | Sylvant |
| Organon LLC | $18.22 | 2023 | Ontruzant |
| Helsinn Therapeutics (U.S.), INC. | $17.96 | 2021 | |
| Heron Therapeutics, INC. | $17.83 | 2022 | |
| Acceleron Pharma, INC. | $13.83 | 2021 | |
| Epizyme, INC. | $12.90 | 2022 |
Drugs and devices associated with these payments
Enhertu $334Keytruda $241Monjuvi $232Lenvima $227Sarclisa $222Jakafi $209Epkinly $208Kisqali $202Imbruvica $194Venclexta $182Nubeqa $180Xofigo $132Verzenio $129Jaypirca $125Elahere $122Lynparza $111Enjaymo $109Libtayo $108Erleada $105Monoferric $104Retevmo $98.11Talvey $95.27Somatuline Depot $94.70Onivyde $94.70Polivy $93.73Pemazyre $90.17Piqray $86.85Ultomiris $85.10Pluvicto $81.32Mekinist $80.68Darzalex $75.84Fabhalta $74.14Welireg $73.74Promacta $69.76Scemblix $65.44Kyprolis $65.22Cablivi $63.51Pemfexy $61.36Carvykti $59.64Brukinsa $59.60Beleodaq $55.48Rezlidhia $49.29Tavalisse $49.29Krazati $48.58Tivdak $48.38Fotivda $48.07Cabometyx $44.85Tecvayli $44.50Blincyto $43.57Vitrakvi $43.39Injectafer $41.03Bavencio $40.37Tukysa $39.49Calquence $36.44Rybrevant $34.40Orserdu $33.30Ninlaro $33.22Talzenna $33.21Xtandi $33.21Orgovyx $33.21Sancuso $33.14Zejula $33.11Jemperli $33.11Tibsovo $33.00Jevtana $31.41Xpovio $30.46Trodelvy $30.09Reblozyl $29.93Tecentriq $29.86Zoladex $29.08Vyloy $28.83Qinlock $28.05Xt Cdx $26.67Elitek $26.46Fruzaqla $25.77Vpriv $25.57Opdivo $24.76Augtyro $24.76Fyarro $24.58Zynyz $24.16Tabrecta $23.91Wavewriter Alpha Prime 16 $23.69Stivarga $23.45Niktimvo $23.28Doptelet $22.88Copiktra $22.61Besremi $22.19Vectibix $21.23Xgeva $21.23Nplate $21.23Poteligeo $20.53Alunbrig $20.48Opdualag $20.17Empaveli $20.12Xalkori $20.04Lorbrena $20.04Braftovi $20.04Mektovi $20.04Sylvant $18.90Zepzelca $18.51
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Bianchini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.